Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells
BioFactors · 2024
DOI: 10.1002/biof.2062 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von David Castro-Vázquez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Faculty of Biological Science, Complutense University of Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Vasoactive Intestinal Peptide, Mesenchymal Stem Cells, Cell Differentiation, Osteogenesis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Economía y Competitividad (Instituto de Salud Carlos III), European regional development fund (ERDF), Instituto de Salud Carlos III.
Abstract (Originalsprache)
Several neuropeptides present in bone tissues, produced by nerve fibers and bone cells, have been reported to play a role in regulating the fine‐tuning of osteoblast and osteoclast functions to maintain bone homeostasis. This study aims to characterize the influence of the neuropeptide vasoactive intestinal peptide (VIP) on the differentiation process of human mesenchymal stem cells (MSCs) into osteoblasts and on their anabolic function. We describe the mRNA and protein expression profile of VIP and its receptors in MSCs as they differentiate into osteoblasts, suggesting the presence of an autocrine signaling pathway in these cells. Our findings reveal that VIP enhances the expression of early osteoblast markers in MSCs under osteogenic differentiation and favors both bone matrix formation and proper cytoskeletal reorganization. Finally, our data suggest that VIP could be exerting a direct modulatory role on the osteoblast to osteoclast signaling by downregulating the receptor activator of nuclear factor‐κB ligand/osteoprotegerin ratio. These results highlight the potential of VIP as an osteoinductive differentiation factor, emerging as a key molecule in the maintenance of human bone homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Faculty of Biological Science, Complutense University of Madrid, Madrid, Spain.
- Departmental Section of Cell Biology, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.
ORCID-Profile: David Castro-Vázquez
Förderung
- Ministerio de Economía y Competitividad (Instituto de Salud Carlos III)
- European regional development fund (ERDF)
- Instituto de Salud Carlos III
Zitieren
APA
Castro-Vázquez, D., Arribas-Castaño, P., García-López, I., Gutiérrez-Cañas, I., Pérez-García, S., Lamana, A., Villanueva-Romero, R., Cabrera-Martín, A., Tecza, K., Martínez, C., Juarranz, Y., Gomariz, R. P., & Carrión, M. (2024). Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells. BioFactors. https://doi.org/10.1002/biof.2062
Vancouver
Castro-Vázquez D, Arribas-Castaño P, García-López I, Gutiérrez-Cañas I, Pérez-García S, Lamana A, et al. Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells. BioFactors. 2024. doi:10.1002/biof.2062
BibTeX
@article{CastroVzquez2024,
author = {Castro-Vázquez, David and Arribas-Castaño, Paula and García-López, Iván and Gutiérrez-Cañas, Irene and Pérez-García, Selene and Lamana, Amalia and Villanueva-Romero, Raúl and Cabrera-Martín, Alicia and Tecza, Karolina and Martínez, Carmen and Juarranz, Yasmina and Gomariz, Rosa P and Carrión, Mar},
title = {Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells},
journal = {BioFactors},
year = {2024},
doi = {10.1002/biof.2062}
}
EUVIMED